Enanta Pharmaceuticals Inc
ENTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001177648
No open-market purchases or sales by Enanta Pharmaceuticals Inc insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $397.2M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Enanta Pharmaceuticals Inc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 147 | 1 | 145 | −1 |
| Shares | 19.2M | 10.7K | 19.9M | +686.1K (+3.6%) |
| Value | $894.5M | $517.0K | $805.3M | −$88.7M (−9.9%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 66,967 | $3.32M | 0.00% |
| Jane Street Group, LLC | 20,186 | $816.3K | 0.00% |
| ExodusPoint Capital Management, LP | 20,147 | $815.0K | 0.01% |
| Point72 Asset Management, L.P. | 11,968 | $484.0K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 10,943 | $442.5K | 0.00% |
| Profund Advisors LLC | 10,605 | $428.9K | 0.03% |
| HRT Financial LP | 10,425 | $421.0K | 0.01% |
| Janus Henderson Group PLC | 8,452 | $341.4K | 0.00% |
| Amundi | 4,633 | $178.3K | 0.00% |
| Point72 Middle East FZE | 4,057 | $164.1K | 0.01% |
| TCI Wealth Advisors, Inc. | 154 | $6.23K | 0.00% |
| Allworth Financial LP | 10 | $405 | 0.00% |
Sold out (13)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Camber Capital Management LP | 110,000 | $5.12M |
| Hillsdale Investment Management Inc. | 53,300 | $2.48M |
| Two Sigma Investments, LP | 32,114 | $1.49M |
| Man Group plc | 13,698 | $637.2K |
| Kiwi Wealth Investments Limited Partnership | 8,380 | $389.8K |
| Dynamic Technology Lab Private Ltd | 7,080 | $329.0K |
| HSBC Holdings PLC | 7,144 | $323.6K |
| AXA S.A. | 6,200 | $288.4K |
| ProShare Advisors LLC | 4,808 | $223.7K |
| D. E. Shaw & Co., Inc. | 4,741 | $220.6K |
| E Fund Management Co., Ltd. | 4,369 | $203.0K |
| Handelsbanken Fonder AB | 4,300 | $200.0K |
| Sutton Wealth Advisors Inc. | 509 | $23.7K |
Not filed for Q1 2023 yet (1)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Comerica Bank | 10,732 | $517.0K |